Sacklers Reach $6 Billion Deal Over Purdue Pharma's OxyContin Lawsuits
March 05, 2022 at 00:05 AM EST
The new deal would restructure the company into a new entity called Knoa Pharma that a public board controls. Family members are relinquishing ownership and must, finally, apologize.
